Press Releases
Quaker Chemical Announces Fourth Quarter And Full Year 2015 Results
- Operating results drive quarterly increase of 6% in adjusted EBITDA despite negative impacts of foreign exchange and lower global steel production
- Fourth quarter restructuring program expected to deliver meaningful savings beginning in 2016
- Strong quarterly cash flow leads to a 34% increase in full year operating cash flow to $73 million
Earnings per diluted share decreased from
Mr. Barry continued, "2015 was the sixth consecutive year of non-GAAP earnings and adjusted EBITDA growth. Looking forward, we see various headwinds that include continued uncertain economic conditions in
Fourth Quarter of 2015 Summary
Net sales for the fourth quarter of 2015 were
Gross profit for the fourth quarter of 2015 decreased
Selling, general and administrative expenses ("SG&A") decreased
The Company had restructuring expenses of
Other income, interest expense and interest income were relatively flat in the fourth quarter of 2015 compared to the fourth quarter of 2014. The Company had slightly higher interest expense on increased average borrowings outstanding and slightly lower third party license fees in the fourth quarter of 2015 as compared to the fourth quarter of 2014.
The Company's effective tax rates for the fourth quarters of 2015 and 2014 were 16.5% and 28.5%, respectively. The primary contributors to the decrease in the fourth quarter of 2015 effective tax rate were accelerated recognition of certain tax-related credits in 2015 due to changes in local tax regulations, adjustments in the fourth quarter of 2015 related to previous years' tax estimates, and the mix of earnings between higher and lower tax jurisdictions.
Equity in net income of associated companies ("equity income") was relatively consistent in the fourth quarter of 2015 compared to the fourth quarter of 2014. The Company had lower equity income from its
The Company had a
During the fourth quarter of 2015, the Company recognized
Changes in foreign exchange rates negatively impacted the Company's fourth quarter of 2015 net income by approximately 5%, or
Year-to-Date 2015 Summary
Net sales for 2015 were
Gross profit for 2015 increased
The increase in SG&A for 2015 of
The Company had restructuring expenses of
Other income for 2015 decreased
Interest expense was
The Company's effective tax rates for 2015 and 2014 were 25.3% and 30.1%, respectively. The primary contributors to the decrease in the 2015 effective tax rate were the mix of earnings between higher and lower tax jurisdictions in 2015, accelerated recognition of certain tax-related credits in 2015 due to changes in local tax regulations, adjustments in 2015 related to previous years' tax estimates, and certain one-time items that inflated the 2014 effective tax rate. Going into 2016, we expect the full year effective tax rate will increase to between 28% and 30%. In addition, the Company expects its quarterly effective tax rates will be higher in the first three quarters of 2016, similar to the 2013 quarterly effective tax rate trend, as the Company will book earnings in one of its subsidiaries at the statutory tax rate of 25% while it awaits recertification of a concessionary 15% tax rate. We currently estimate our first quarter of 2016 effective tax rate will be between 31% and 33%.
Equity income for 2015 decreased
The
Excluding the one-time transaction-related expenses mentioned above, the Company recognized a minimal impact to net income from its 2015 Verkol acquisition, as its operating results were offset by normal acquisition-related costs and initial adjustments related to fair value accounting.
Changes in foreign exchange rates, excluding the currency conversion impacts of the Venezuelan bolivar fuerte noted above, negatively impacted the Company's 2015 net income by approximately 7%, or
Balance Sheet and Cash Flow Items
The Company's net operating cash flow of
Non-GAAP Measures
Included in this public release are non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. The following are reconciliations between the non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP financial measures:
Three Months Ended December 31, |
Twelve Months Ended December 31, |
|||||||||
2015 |
2014 |
2015 |
2014 |
|||||||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders |
$ 0.86 |
$ 0.95 |
$ 3.84 |
$ 4.26 |
||||||
Equity income in a captive insurance company per diluted share |
(0.07) |
(0.02) |
(0.16) |
(0.18) |
||||||
Restructuring expenses per diluted share |
0.36 |
— |
0.36 |
— |
||||||
Verkol transaction-related expenses per diluted share |
— |
— |
0.15 |
— |
||||||
U.K. pension plan amendment per diluted share |
— |
— |
— |
0.05 |
||||||
Customer bankruptcy costs per diluted share |
0.01 |
0.03 |
0.02 |
0.05 |
||||||
Cost streamlining initiatives per diluted share |
— |
0.04 |
0.01 |
0.06 |
||||||
Currency conversion impact of the Venezuelan bolivar fuerte per diluted share |
— |
— |
0.21 |
0.02 |
||||||
Non-GAAP earnings per diluted share |
$ 1.16 |
$ 1.00 |
$ 4.43 |
$ 4.26 |
Three Months Ended December 31, |
Twelve Months Ended December 31, |
|||||||||
2015 |
2014 |
2015 |
2014 |
|||||||
Net income attributable to Quaker Chemical Corporation |
$ 11,393 |
$ 12,639 |
$ 51,180 |
$ 56,492 |
||||||
Depreciation and amortization |
4,979 |
4,723 |
19,206 |
16,631 |
||||||
Interest expense |
694 |
624 |
2,585 |
2,371 |
||||||
Taxes on income before equity in net income of associated companies |
2,161 |
4,731 |
17,785 |
23,539 |
||||||
Equity income in a captive insurance company |
(857) |
(270) |
(2,078) |
(2,412) |
||||||
Restructuring expenses |
6,790 |
— |
6,790 |
— |
||||||
Verkol transaction-related expenses |
— |
— |
2,813 |
— |
||||||
U.K. pension plan amendment |
— |
— |
— |
902 |
||||||
Customer bankruptcy costs |
149 |
515 |
328 |
825 |
||||||
Cost streamlining initiatives |
— |
818 |
173 |
1,166 |
||||||
Currency conversion impact of the Venezuelan bolivar fuerte |
— |
— |
2,806 |
321 |
||||||
Adjusted EBITDA |
$ 25,309 |
$ 23,780 |
$ 101,588 |
$ 99,835 |
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
|||||||
Consolidated Statements of Income |
|||||||
(Dollars in thousands, except per share data) |
|||||||
Three Months Ended December 31, |
Twelve Months Ended December 31, |
||||||
2015 |
2014 |
2015 |
2014 |
||||
Net sales |
$ 183,275 |
$ 194,033 |
$ 737,555 |
$ 765,860 |
|||
Cost of goods sold |
114,509 |
124,457 |
460,515 |
492,654 |
|||
Gross profit |
68,766 |
69,576 |
277,040 |
273,206 |
|||
% |
37.5% |
35.9% |
37.6% |
35.7% |
|||
Selling, general and administrative expenses |
48,753 |
53,091 |
198,990 |
195,850 |
|||
Restructuring and related activities |
6,790 |
- |
6,790 |
- |
|||
Operating income |
13,223 |
16,485 |
71,260 |
77,356 |
|||
% |
7.2% |
8.5% |
9.7% |
10.1% |
|||
Other income (expense), net |
28 |
209 |
(69) |
767 |
|||
Interest expense |
(694) |
(624) |
(2,585) |
(2,371) |
|||
Interest income |
507 |
551 |
1,624 |
2,541 |
|||
Income before taxes and equity in net income of associated companies |
13,064 |
16,621 |
70,230 |
78,293 |
|||
Taxes on income before equity in net income of associated companies |
2,161 |
4,731 |
17,785 |
23,539 |
|||
Income before equity in net income of associated companies |
10,903 |
11,890 |
52,445 |
54,754 |
|||
Equity in net income of associated companies |
949 |
1,037 |
261 |
3,543 |
|||
Net income |
11,852 |
12,927 |
52,706 |
58,297 |
|||
Less: Net income attributable to noncontrolling interest |
459 |
288 |
1,526 |
1,805 |
|||
Net income attributable to Quaker Chemical Corporation |
$ 11,393 |
$ 12,639 |
$ 51,180 |
$ 56,492 |
|||
% |
6.2% |
6.5% |
6.9% |
7.4% |
|||
Per share data: |
|||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic |
$ 0.86 |
$ 0.95 |
$ 3.84 |
$ 4.27 |
|||
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted |
$ 0.86 |
$ 0.95 |
$ 3.84 |
$ 4.26 |
|||
Quaker Chemical Corporation |
|||
Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value and share amounts) |
|||
December 31, |
|||
2015 |
2014 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 81,053 |
$ 64,731 |
|
Accounts receivable, net |
188,297 |
189,484 |
|
Inventories, net |
75,099 |
77,708 |
|
Current deferred tax assets |
7,822 |
8,367 |
|
Prepaid expenses and other current assets |
13,582 |
11,228 |
|
Total current assets |
365,853 |
351,518 |
|
Property, plant and equipment, net |
87,619 |
85,763 |
|
Goodwill |
79,111 |
77,933 |
|
Other intangible assets, net |
73,287 |
70,408 |
|
Investments in associated companies |
20,354 |
21,751 |
|
Non-current deferred tax assets |
27,071 |
24,411 |
|
Other assets |
32,218 |
33,742 |
|
Total assets |
$ 685,513 |
$ 665,526 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 662 |
$ 403 |
|
Accounts payable |
67,291 |
74,987 |
|
Dividends payable |
4,252 |
3,990 |
|
Accrued compensation |
19,166 |
19,853 |
|
Accrued restructuring |
6,303 |
- |
|
Accrued pension and postretirement benefits |
1,144 |
1,239 |
|
Current deferred tax liabilities |
41 |
732 |
|
Other current liabilities |
25,696 |
23,697 |
|
Total current liabilities |
124,555 |
124,901 |
|
Long-term debt |
81,439 |
75,328 |
|
Non-current deferred tax liabilities |
15,003 |
8,584 |
|
Non-current accrued pension and postretirement benefits |
40,689 |
46,088 |
|
Other non-current liabilities |
42,584 |
45,490 |
|
Total liabilities |
304,270 |
300,391 |
|
Equity |
|||
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2015 - 13,288,113 shares; 2014 - 13,300,891 shares |
13,288 |
13,301 |
|
Capital in excess of par value |
106,333 |
99,056 |
|
Retained earnings |
326,740 |
299,524 |
|
Accumulated other comprehensive loss |
(73,316) |
(54,406) |
|
Total Quaker shareholders' equity |
373,045 |
357,475 |
|
Noncontrolling interest |
8,198 |
7,660 |
|
Total equity |
381,243 |
365,135 |
|
Total liabilities and equity |
$ 685,513 |
$ 665,526 |
|
Quaker Chemical Corporation |
|||
Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
Twelve Months Ended December 31, |
|||
2015 |
2014 |
||
Cash flows from operating activities |
|||
Net income |
$ 52,706 |
$ 58,297 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|||
Depreciation |
12,395 |
12,306 |
|
Amortization |
6,811 |
4,325 |
|
Equity in undistributed earnings of associated companies, net of dividends |
578 |
(3,180) |
|
Deferred income taxes |
(2,401) |
1,007 |
|
Uncertain tax positions (non-deferred portion) |
(1,122) |
(1,256) |
|
Deferred compensation and other, net |
14 |
3,174 |
|
Stock-based compensation |
5,919 |
5,309 |
|
Restructuring and related activities |
6,790 |
- |
|
Gain on disposal of property, plant and equipment and other assets |
(12) |
(86) |
|
Insurance settlement realized |
(760) |
(1,907) |
|
Pension and other postretirement benefits |
2,591 |
1,265 |
|
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions: |
|||
Accounts receivable |
(188) |
(24,944) |
|
Inventories |
1,292 |
(5,484) |
|
Prepaid expenses and other current assets |
(721) |
2,003 |
|
Accounts payable and accrued liabilities |
(9,040) |
2,999 |
|
Change in restructuring liabilities |
(490) |
- |
|
Estimated taxes on income |
(930) |
862 |
|
Net cash provided by operating activities |
73,432 |
54,690 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(11,033) |
(13,052) |
|
Payments related to acquisitions, net of cash acquired |
(24,058) |
(73,527) |
|
Proceeds from disposition of assets |
135 |
201 |
|
Insurance settlement interest earned |
35 |
44 |
|
Change in restricted cash, net |
725 |
1,863 |
|
Net cash used in investing activities |
(34,196) |
(84,471) |
|
Cash flows from financing activities |
|||
Proceeds from long-term debt |
6,163 |
58,771 |
|
Repayment of long-term debt |
(477) |
(1,368) |
|
Dividends paid |
(16,513) |
(14,562) |
|
Stock options exercised, other |
1,048 |
804 |
|
Payments for repurchase of common stock |
(7,276) |
- |
|
Excess tax benefit related to stock option exercises |
384 |
453 |
|
Purchase of noncontrolling interest in affiliates, net |
- |
(7,422) |
|
Payment of acquisition-related liabilities |
(226) |
(4,709) |
|
Distributions to noncontrolling affiliate shareholders |
- |
(1,806) |
|
Net cash (used in) provided by financing activities |
(16,897) |
30,161 |
|
Effect of exchange rate changes on cash |
(6,017) |
(4,141) |
|
Net increase (decrease) in cash and cash equivalents |
16,322 |
(3,761) |
|
Cash and cash equivalents at the beginning of the period |
64,731 |
68,492 |
|
Cash and cash equivalents at the end of the period |
$ 81,053 |
$ 64,731 |
|
Logo - http://photos.prnewswire.com/prnh/20120910/PH70044LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quaker-chemical-announces-fourth-quarter-and-full-year-2015-results-300226454.html
SOURCE
Mary Dean Hall, Vice President, Chief Financial Officer and Treasurer, Hallm@quakerchem.com, T. 610.832.4160